Comparable stake leader
SAPIENT CAPITAL LLC
SEC ownership of INTENSITY THERAPEUTICS, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001567264.
Disclosed value leader
Kingsbury Capital Investment Advisors LLC
Comparable rows
2/25
Latest evidence
16 Jul 2026
- Public ticker
- INTS on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
SAPIENT CAPITAL LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
2 of 25
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
SAPIENT CAPITAL LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
16 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001567264
- Issuer location
- Shelton, CT
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of INTENSITY THERAPEUTICS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SAPIENT CAPITAL LLC
Disclosed value leader
Kingsbury Capital Investm...
Comparable rows
2/25
Latest evidence
16 Jul 2026
13D/G
13F
3/4/5
Lead comparable stake: 3.9%
23 rows are not safely comparable across share classes.
13D/G row: SAPIENT CAPITAL LLC
Showing 1-8 of 25 holder rows.
Quick read
SAPIENT CAPITAL LLC leads the comparable SEC ownership view at 3.9%.
2 of 25 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SAPIENT CAPITAL LLC's linked filing trail.
Comparable ownership
Top 2
SAPIENT CAPITAL LLC
3.9%
ARMISTICE CAPITAL, LLC
2.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 25 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SAPIENT CAPITAL LLC |
13D/G
13F
Company
|
3.9%
|
$312,575
976,797 shares
|
-$11,287 | 30 Jun 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
2.6%
|
$383,505
1,237,113 shares
|
+$113,015 | 30 Jun 2025 |
| Kingsbury Capital Investment Advisors LLC |
13F
Company
|
—
class O/S missing
|
$2,035,621
496,493 shares
|
— | 30 Jun 2026 |
| KMT WEALTH MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$2,035,621
496,493 shares
|
— | 30 Jun 2026 |
| Rothschild Wealth LLC |
13F
Company
|
—
class O/S missing
|
$109,564
26,723 shares
|
— | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
class O/S missing
|
$108,933
26,569 shares
|
— | 30 Jun 2026 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P |
13F
Company
|
—
class O/S missing
|
$102,500
25,000 shares
|
— | 30 Jun 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$93,426
22,787 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 14 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-8 of 8 reporting-owner rows connected to INTENSITY THERAPEUTICS, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
8
Largest Forms 3/4/5 holder
Lewis H. Bender
Net 12M change
$0
Latest report
16 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Lewis H. Bender | President and CEO, Director | $48,628 | Mixed | 16 Jul 2026 | ||
| John M. Wesolowski | Principal Accounting Officer | $41,759 | Mixed | 16 Jul 2026 | ||
| Joseph Talamo | Chief Financial Officer | $13,165 | Mixed | 16 Jul 2026 | ||
| James M. Ahlers | Executive VP of CF | Mixed | 29 Jun 2023 | |||
| Thomas I. H. Dubin | Director | Mixed | 16 Jul 2026 | |||
| Emer Leahy | Director | Mixed | 16 Jul 2026 | |||
| Mark A. Goldberg | Director | Mixed | 16 Jul 2026 | |||
| Daniel Donovan | Director | Mixed | 16 Jul 2026 |
Recent insider transactions for INTENSITY THERAPEUTICS, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Thomas I. H. Dubin | INTS | Stock Option (right to buy Common Stock) | Award | 5,500 | 5,500 | 16 Jul 2026 | Direct | |||
| Daniel Donovan | INTS | Stock Option (right to buy Common Stock) | Award | 5,500 | 5,500 | 16 Jul 2026 | Direct | |||
| Mark A. Goldberg | INTS | Stock Option (right to buy Common Stock) | Award | 5,500 | 5,500 | 16 Jul 2026 | Direct | |||
| Emer Leahy | INTS | Stock Option (right to buy Common Stock) | Award | 5,500 | 5,500 | 16 Jul 2026 | Direct | |||
| John M. Wesolowski | INTS | Stock Option (right to buy Common Stock) | Award | 11,000 | 11,000 | 16 Jul 2026 | Direct | |||
| Joseph Talamo | INTS | Stock Option (right to buy Common Stock) | Award | 34,000 | 34,000 | 16 Jul 2026 | Direct | |||
| Lewis H. Bender | INTS | Stock Option (right to buy Common Stock) | Award | 78,000 | 78,000 | 16 Jul 2026 | Direct | |||
| John M. Wesolowski | INTS | Common Stock, $0.0001 Par Value | Award | 108% | 3,688 | 7,102 | 30 Jun 2026 | Direct | ||
| Joseph Talamo | INTS | Common Stock, $0.0001 Par Value | Award | 95.4% | 1,093 | 2,239 | 30 Jun 2026 | Direct | ||
| Lewis H. Bender | INTS | Common Stock, $0.0001 Par Value | Award | 46.7% | 37,749 | 118,549 | 26 Mar 2026 | Direct | ||
| John M. Wesolowski | INTS | Common Stock, $0.0001 Par Value | Award | 11.7% | 8,918 | 85,354 | 31 Dec 2025 | Direct | ||
| Joseph Talamo | INTS | Common Stock, $0.0001 Par Value | Award | 102.1% | 14,482 | 28,661 | 31 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.